AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2018
Feb 1, 2018
31982_dirs_2018-02-01_1120431a-8d82-4b21-b4b2-ef87c517d99f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2018-01-31
Reporting Person: Glenn Gregory M (President, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-31 | Common Stock | P | 12784 | $0.88 | Acquired | 27211 | Direct |
Footnotes
F1: Includes 12,784 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on January 31, 2018.